United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - protirelin (unii: 5y5f15120w) (protirelin - unii:5y5f15120w) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - protirelin (unii: 5y5f15120w) (protirelin - unii:5y5f15120w) -

United States - English - NLM (National Library of Medicine)

suzhou qianyuan biotechnology co., ltd. - protirelin (unii: 5y5f15120w) (protirelin - unii:5y5f15120w) -

Malta - English - Medicines Authority

p & d pharmaceuticals limited - protirelin 100 µg/ml - solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - protirelin - solution for injection - 100microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - protirelin - solution for injection - 100microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - protirelin - solution for injection - 100microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - protirelin - solution for injection - 200microgram/1ml

United States - English - NLM (National Library of Medicine)

zhejiang peptites biotech co.,ltd. - protirelin (unii: 5y5f15120w) (protirelin - unii:5y5f15120w) -

United States - English - NLM (National Library of Medicine)

anazaohealth corporation - protirelin (unii: 5y5f15120w) (protirelin - unii:5y5f15120w) - protirelin 500 ug in 1 ml - trh is indicated as an adjunctive agent in the diagnostic assessment of thyroid function. as an adjunct to other diagnostic procedures, testing with trh (protirelin) may yield useful information in patients with pituitary or hypothalamic dysfunction. trh is indicated as an adjunct to evaluate the effectiveness of thyrotropin suppression with a particular dose of t4 in patients with nodular or diffuse goiter. a normal tsh baseline value and a minimal difference between the 30 minute and baseline response to trh injection would indicate adequate suppression of the pituitary secretion of tsh. trh may be used, adjunctively, for adjustment of thyroid hormone dosage given to patients with primary hypothyroidism. a normal or slightly blunted tsh response, thirty minutes following trh injection, would indicate adequate replacement therapy.